Checkpoint Trends Ltd.

CHECKPOINT

₹36.45

-1.99% (-0.74)

Market Cap

₹20 Cr.

P/E

223.95

Key Ratios

Edit Ratio's

Market cap

20.00 Cr

223

Prom Holding

ROE (%)

5.67

ROCE (%)

4.32

Div Yield (%)

Sales

12.11 Cr

OPM (%)

0.97 %

Debt to Equity

Edit Ratio's

About

Rubra Medicaments Ltd was Incrporated in the year of 1991. The company is in the business acti… Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

6 Yes

Positive for this company

3 Neutral

Neutral for this company

6 No

Negative for this company

2 No Data

Insufficient data to analyse

Accounting & Shareholding

Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Contingent Liabilities

Unable to calculate due to limited data

Price & Performance

Capex vs ROCE

Company has maintained it roce despite making significant capex
Debt

Company should not have issues servicing its debt
ROE

Financial leverage has increased roe over 10 years
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Share price

Share price has increased over last 10 years but more due to rerating
Working Capital

Company has significant working capital which is dragging its roce and roe
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Current vs Historic Valuation

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Checkpoint Trends Ltd. Business

What does Rubra Medicaments do?

Rubra Medicaments Ltd, established in 1991, is engaged in the non-specialized wholesale trade, focusing on traded goods.

Who are the competitors of Rubra Medicaments?

Rubra Medicaments major competitors are Samyak International, Regent Enterprises, Lypsa Gems, White Organic Agro, Northlink Fiscal, Vasudhagama Enterprs, OP Chains.
Market Cap of Rubra Medicaments is ₹20 Crs.
While the median market cap of its peers are ₹20 Crs.

Is Rubra Medicaments financially stable compared to its competitors?

Rubra Medicaments seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Checkpoint Trends Ltd.

Checkpoint Trends Ltd.

Key Ratios

About

Timeline

Company Timeline

6 Yes

3 Neutral

6 No

2 No Data

Accounting & Shareholding

Depreciation Effect

Other Income

Pledge

Revenue Recognition

Promoter Holding

Retail Holding

Contingent Liabilities

Price & Performance

Capex vs ROCE

Debt

ROE

Balance Sheet Strength

Share price

Working Capital

Sales Growth

Margin Stability

ROCE Strength

Current vs Historic Valuation

Product Wise Break-Up

UNLOCK PREMIUM

What does Rubra Medicaments do?

Who are the competitors of Rubra Medicaments?

Is Rubra Medicaments financially stable compared to its competitors?

SIGN UP FOR FREE